So what if tangles precede plaques?

Neurobiology of Aging

Volumn 25, Issue 6, 2004, Pages 721-723

  Price, J L ^a   Morris, J C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN INJURY; CONCENTRATION (PARAMETERS); GENE MUTATION; NEUROFIBRILLARY TANGLE; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ALZHEIMER DISEASE; DEMENTIA; HUMANS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; SENILE PLAQUES;

EID: 2542518477     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.12.017     Document Type: Note

References (26)

1. Arriagada P.V., Marzloff K., Hyman B.T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 42:1992;1681-1688
2. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 18:1997;351-357
3. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 38:1988;1682-1687
4. Duyckaerts C., Hauw J.J. Prevalence; incidence and duration of Braak's stages in the general population: can we know? Neurobiol. Aging. 18:1997;362-369
5. Goldman W.P., Price J.L., Storandt M., Grant E.A., McKeel D.W. Jr., Rubin E.H., et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology. 56:2001;361-367
6. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons distinguishes very mild Alzheimer's disease from nondemented aging. J. Neurosci. 16:1996;4491-4500
7. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41:1997;17-24
8. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185
9. Hof P.R., Bouras C., Perl D.P., Sparks D.L., Mehta N., Morrison J.H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch. Neurol. 52:1995;379-391
10. Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23:1988;138-144
11. Mann D.M., Yates P.O., Marcyniuk B., Ravindra C.R. The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol. Appl. Neurobiol. 12:1986;447-457
12. Mann D.M., Esiri M.M. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J. Neurol. Sci. 89:1989;169-179
13. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486
14. Morris J.C., Storandt M., McKeel D.W., Rubin E.H., Price J.L., Grant E.A., et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 46:1996;707-719
15. Morris J.C., Price J.L. Pathological correlates of nondemented aging mild cognitive impairment and early stage Alzheimer's disease. J. Mol. Neursoci. 17:2001;101-118
16. National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-2.
17. Price J.L., Davis P.B., Morris J.C., White D.L. The distribution of tangles; plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 12:1991;295-312
18. Price J.L. Tangles and plaques in healthy aging and Alzheimer's disease. Independence or interaction? Semin. Neurosci. 6:1994;395-402
19. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 45:1999;13290-13295
20. Price J.L., Ko A.I., Wade M.J., Tsou S.K., McKeel D.W., Morris J.C. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch. Neurol. 58:2001;1395-1402
21. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N.Y. Acad. Sci. 924:2000;17-25
22. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766
23. Silverman W., Wisniewski H.M., Bobinski M., Wegiel J. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 18:1997;377-379
24. Tomlinson B.E., Blessed G., Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci. 7:1968;331-356
25. Troncoso J.C., Martin L.J., Dal Forno G., Kawas C.H. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol. Aging. 17:1996;365-371
26. Wisniewski K.E., Wisniewski H.M., Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:1985;278-282